|
Market Closed -
London S.E.
10:45:34 2025-11-03 EST
|
After hours 11:25:00 | |||
| 31.92 SEK | -32.03% |
|
0.1580 | -99.51% |
| 09-03 | Six stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 09-01 | 17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
Company Valuation: Immunovia AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,697 | 595.2 | 92.66 | 152.7 | 96.06 | - | - |
| Change | - | -64.93% | - | 64.79% | -37.09% | - | - |
| Enterprise Value (EV) 1 | 1,443 | 526.7 | 92.66 | 76.09 | 61.06 | 66.06 | 41.06 |
| Change | - | -63.5% | - | -17.88% | -19.76% | 8.19% | -37.85% |
| P/E | -0.11x | -0.04x | -0.01x | -0.54x | -1.43x | -3.57x | -7.14x |
| PBR | 0.04x | 0.02x | - | - | - | - | - |
| PEG | - | -0.01x | - | 0x | 0x | 0.1x | 0.1x |
| Capitalization / Revenue | 1,775x | 494x | - | 203x | 30x | 5.55x | 1.75x |
| EV / Revenue | 1,510x | 437x | - | 101x | 19.1x | 3.82x | 0.75x |
| EV / EBITDA | -9.78x | -3.17x | - | -0.97x | -0.72x | -0.89x | -0.98x |
| EV / EBIT | -8.66x | -2.76x | - | -0.95x | -0.69x | -0.87x | -0.91x |
| EV / FCF | -9.27x | -2.97x | - | -0.91x | -0.7x | -0.83x | -0.82x |
| FCF Yield | -10.8% | -33.6% | - | -110% | -142% | -121% | -122% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -689 | -743 | -93 | -0.42 | -0.1 | -0.04 | -0.02 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.956 | 1.204 | - | 0.752 | 3.2 | 17.3 | 55 |
| EBITDA 1 | -147.6 | -166.2 | - | -78.06 | -85 | -74 | -42 |
| EBIT 1 | -166.6 | -191.2 | - | -80.38 | -88 | -76 | -45 |
| Net income 1 | -156 | -168.1 | -76.54 | -145.9 | -87 | -76 | -45 |
| Net Debt 1 | -254.1 | -68.47 | - | -76.6 | -35 | -30 | -55 |
| Reference price 2 | 75.0000 | 26.3000 | 0.5460 | 0.2270 | 0.1428 | 0.1428 | 0.1428 |
| Nbr of stocks (in thousands) | 22,632 | 22,632 | 169,711 | 672,667 | 672,667 | - | - |
| Announcement Date | 2/17/22 | 2/23/23 | 2/25/25 | 2/24/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 61.07x | 4.84x | 16.16x | 0.34% | 16.73B | |
| 40.46x | - | - | 2% | 1.75B | |
| 15.03x | 2.06x | 6.98x | 1.71% | 893M | |
| -2.86x | 1.38x | 6.41x | - | 808M | |
| 39.28x | - | - | - | 778M | |
| 114.66x | - | - | 1.02% | 560M | |
| 33.35x | 2.85x | 16.96x | -.--% | 450M | |
| 27.68x | 4.72x | 16.11x | 1.7% | 397M | |
| Average | 41.08x | 3.17x | 12.52x | 1.13% | 2.8B | |
| Weighted average by Cap. | 54.74x | 4.51x | 15.35x | 0.58% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
- Valuation Immunovia AB
Select your edition
All financial news and data tailored to specific country editions
